scispace - formally typeset
L

Lauren Eadie

Researcher at University of British Columbia

Publications -  8
Citations -  135

Lauren Eadie is an academic researcher from University of British Columbia. The author has contributed to research in topics: Medicine & Cannabis. The author has an hindex of 2, co-authored 5 publications receiving 9 citations.

Papers
More filters
Journal ArticleDOI

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

Obbina Abani, +7885 more
- 03 Mar 2022 - 
TL;DR: In patients hospitalised with COVID-19, baricitinib significantly reduced the risk of death but the size of benefit was somewhat smaller than that suggested by previous trials.
Journal ArticleDOI

Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review.

TL;DR: A systematic electronic search for English language randomized controlled trials (RCTs), clinical trials and systematic reviews (in order to capture any potentially missed RCTs) between 2000 and 2019 was conducted through Ovid MEDLINE and EMBASE electronic databases using MeSH terms.
Journal ArticleDOI

Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain.

TL;DR: In this article, a clinical tool for the initiation of medical cannabis in the management of chronic non-cancer pain (CNCP) patients using chronic opioid therapy is presented. And the authors suggest that low dose THC is introduced as an adjunctive therapy with or without opioids to optimize pain control.
Journal ArticleDOI

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, +7999 more
- 01 Apr 2023 - 
Journal ArticleDOI

Cannabidiol‐associated hepatotoxicity: A systematic review and meta‐analysis

TL;DR: In this paper , the association between cannabidiol use, liver enzyme elevation, and drug-induced liver injury (DILI) was determined, which raised concerns over liver safety.